By Ramsey Baghdadi
There was a telling exchange between Food & Drug Administration commissioner Andrew von Eschenbach and Massachusetts Democrat John Tierney during...
Tone Deaf: FDA Commissioner Hits the Wrong Note
Listen to this article
When Andrew von Eschenbach was coaxed to come over from NCI to lead FDA, he seemed like a perfect choice to right the ship and manage FDA through the final years of the Bush Administration. But, as the hoopla over Avandia shows, the ship is still taking on water. The commissioner’s tone and vision aren’t helping.
Learn what's happening at the US FDA. On the go.
More from Agency Leadership
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
More from Pink Sheet
- • By
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
- • By
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
- • By
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
